Search

Author/Creator Limpastan, Kriengsak

1. Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors. (2nd April 2016)

Authors:
Nanegrungsunk, Danop; Apaijai, Nattayaporn; Yarana, Chontida; Sripetchwandee, Jirapas; Limpastan, Kriengsak; Watcharasaksilp, Wanarak; Vaniyapong, Tanat; Chattipakorn, Nipon; Chattipakorn, Siriporn C
Journal:
Neurological research
Issue:
Volume 38:Number 4(2016)
Page Start:
285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Myeloid differentiation factor 2 inhibitor, 2i‐10, alleviates dendritic spine loss in rats with cardiac ischemia‐reperfusion injury via decreasing brain inflammation. (1st February 2022)

Authors:
Vongsfak, Jirapong; Apaijai, Nattayaporn; Maneechote, Chayadom; Chunchai, Titikorn; Arunsak, Busarin; Liang, Guang; Limpastan, Kriengsak; Chattipakorn, Nipon; Chattipakorn, Siriporn C
Journal:
Alzheimer's & dementia
Issue:
Volume 17:(2021)Supplement 3
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Myeloid differentiation factor 2 inhibitor, 2i‐10, alleviates dendritic spine loss in rats with cardiac ischemia‐reperfusion injury via decreasing brain inflammation. (December 2021)

Authors:
Vongsfak, Jirapong; Apaijai, Nattayaporn; Maneechote, Chayadom; Chunchai, Titikorn; Arunsak, Busarin; Liang, Guang; Limpastan, Kriengsak; Chattipakorn, Nipon; Chattipakorn, Siriporn C
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 3
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗